XM không cung cấp dịch vụ cho cư dân của Mỹ.
A
A

AstraZeneca


Tin tức

US natgas prices slip 2% on mild forecasts, rising storage levels

UPDATE 1-US natgas prices slip 2% on mild forecasts, rising storage levels Adds latest prices U.S. weather to remain mild through mid November Gas stockpiles rising at faster-than-normal pace NYMEX open interest hits record high By Scott DiSavino Nov 1 (Reuters) - U.S. natural gas futures slid about 2% on Friday on forecasts for mild weather to continue through mid-November, keeping heating demand lower than usual for this time of year and allowing utilities to add more gas into storage for at l
A
N

US natgas prices ease 1% on mild forecasts, rising storage levels

US natgas prices ease 1% on mild forecasts, rising storage levels U.S. weather to remain mild through mid November Gas stockpiles rising at faster-than-normal pace NYMEX open interest hits record high By Scott DiSavino Nov 1 (Reuters) - U.S. natural gas futures eased about 1% on Friday on forecasts for mild weather to continue through mid-November, keeping heating demand lower than usual for this time of year and allowing utilities to add more gas into storage for at least a few more weeks.
A
N

US natgas prices drop 5% on mild weather forecasts, big storage injection

UPDATE 2-US natgas prices drop 5% on mild weather forecasts, big storage injection Mild weather should keep heating demand lower than usual EIA reports gas storage build above five-year average Analysts project average gas output to decline in 2024 Adds latest prices By Scott DiSavino Oct 31 (Reuters) - U.S. natural gas futures dropped about 5% on Thursday due to an expected bigger-than-usual storage build and forecasts for mild weather to continue through mid-November.
A
N

Financial Times - Oct 31

PRESS DIGEST- Financial Times - Oct 31 Oct 31 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Siemens to buy simulation software group Altair for $10.6 bln - Authorities investigate fire at UK nuclear submarine shipyard - Ikea to pay 6 mln euros to compensate for forced labour by ex-prisoners in East Germany - Harvey Schwartz and Peter Mandelson quit Bank of London board - AstraZeneca
A
B
S

British Business - Oct 31

PRESS DIGEST-British Business - Oct 31 Oct 31 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times Bank of London said on Wednesday that deputy chairman Lord Mandelson and chairman Harvey Schwartz are leaving as part of a boardroom exodus after the financial technology start-up was thrown into turmoil last month.
A
T

Drugmakers urge appeals court to revive challenge to US drug price negotiation program

Drugmakers urge appeals court to revive challenge to US drug price negotiation program By Brendan Pierson Oct 30 (Reuters) - Lawyers for AstraZeneca AZN.L , Bristol Myers Squibb BMY.N and Johnson & Johnson's JNJ.N Janssen on Wednesday urged a federal appeals court in Philadelphia to revive their lawsuits challenging the first-ever U.S. law requiring pharmaceutical companies to negotiate drug prices with the government's Medicare health insurance program that covers 66 million people.
A

London's FTSE 100 falls after Labour's first budget

UPDATE 1-London's FTSE 100 falls after Labour's first budget UK budget declares tax rise AstraZeneca falls on China probe GSK warns of lower 2024 vaccine sales, shares fall FTSE 100 down 0.7%, FTSE up 250 up 0.3% Updated at 1652 GMT By Shubham Batra and Nikhil Sharma Oct 30 (Reuters) - The UK's FTSE 100 fell to an over two-month low on Wednesday, dragged down by the healthcare sector, while midcap stocks got a lift even as the latest UK budget came with the biggest tax increases in three decades
A
D
E
H
S
U

US natural gas prices ease 1% as mild weather forecasts keep heating demand low

US natural gas prices ease 1% as mild weather forecasts keep heating demand low Mild weather expected to continue through mid-November December contract still up about 21% to three-week high Analysts project average gas output to decline in 2024 By Scott DiSavino Oct 30 (Reuters) - U.S. natural gas futures eased about 1% on Wednesday on forecasts for mild weather to continue through mid-November, keeping heating demand low and allowing utilities to inject more gas into storage than normal for a
A
N

AstraZeneca falls after China operations president under investigation

BUZZ-AstraZeneca falls after China operations president under investigation ** Shares of AstraZeneca AZN.L fall 2.8% to 11,210p, lowest since April 22 ** Stock among top losers on FTSE 100 .FTSE index ** Drugmaker says its China operations president is under investigation and is cooperating with authorities ** Operations in the country continue und
A
U

AstraZeneca says its China operations president under investigation

UPDATE 5-AstraZeneca says its China operations president under investigation Not clear what the investigation is about or if Wang is detained AstraZeneca employees were detained in September Chinese media have reported on other AstraZeneca-related probes Updates Oct. 30 story throughout, adding details about Wang and AstraZeneca-related investigations in China By Maggie Fick and Casey Hall LONDON/SHANGHAI, Oct 31 (Reuters) - AstraZeneca AZN.L said its China president Leon Wang is under investiga
A

US natgas prices climb 2% on contract expiry, forecasts for more demand next week

UPDATE 1-US natgas prices climb 2% on contract expiry, forecasts for more demand next week Adds latest prices By Scott DiSavino Oct 29 (Reuters) - U.S. natural gas futures gained about 2% in volatile trade on Tuesday on a one-day drop in output and forecasts for slightly cooler weather and a little more heating demand next week than previously expected.
A
N

US natgas prices fall 5% to 7-week low on mild forecasts, mostly rising output

US natgas prices fall 5% to 7-week low on mild forecasts, mostly rising output By Scott DiSavino Oct 29 (Reuters) - U.S. natural gas futures fell about 5% to a seven-week low on Tuesday on forecasts for mild weather through at least mid-November and an increase in output over most of the past several days. On the last day as the front-month, gas futures NGc1 for November delivery on the New York Mercantile Exchange fell 10.8 cents, or 4.7%, to $2.201 per million British thermal units (mmBtu) by
A
N

Microcap Monopar Therapeutics tumbles on planned stock offering

BUZZ-Microcap Monopar Therapeutics tumbles on planned stock offering ** Shares of Monopar Therapeutics MNPR.O tumble ~18% to $14.65 post-market after co unveils planned equity raise ** Co announces stock offering on best effort basis; deal size not disclosed ** It plans to use net proceeds for general purposes, including R&D, clinical trial expenditures, among other uses ** Co has 3.9 mln shares outstanding for ~$70 mln market cap and ~2 mln shares of free float, per LSEG ** MNPR closed Monday's
A

US natgas prices dive 10% on mild forecasts, rising output

UPDATE 1-US natgas prices dive 10% on mild forecasts, rising output Adds latest prices By Scott DiSavino Oct 28 (Reuters) - U.S. natural gas futures plunged about 10 % on Monday to a one-week low, on forecasts for mild weather through at least mid-November, less demand next week than previously expected and an increase in output in recent days. Another factor weighing on gas prices was a 6% drop in oil futures on Monday after a limited Israeli attack on Iran over the weekend.
A

US natgas prices drop 8% on mild forecasts, rising output

US natgas prices drop 8% on mild forecasts, rising output By Scott DiSavino Oct 28 (Reuters) - U.S. natural gas futures dropped about 8% on Monday on forecasts for mild weather through at least mid-November, less demand next week than previously expected and an increase in output in recent days. Another factor weighing on gas prices was a 6% drop in oil futures on Monday after a limited Israeli attack on Iran over the weekend.
A
N

Astrazeneca Reports 9.9% Passive Stake In Monopar Therapeutics As Of Oct 23 - SEC Filing

BRIEF-Astrazeneca Reports 9.9% Passive Stake In Monopar Therapeutics As Of Oct 23 - SEC Filing Oct 28 (Reuters) - ASTRAZENECA REPORTS 9.9% PASSIVE STAKE IN MONOPAR THERAPEUTICS AS OF OCT 23 - SEC FILING Source text: [ID:n0001104659-24-111584]
A

AstraZeneca Says Fasenra Approved In The EU For Eosinophilic Granulomatosis With Polyangiitis

BRIEF-AstraZeneca Says Fasenra Approved In The EU For Eosinophilic Granulomatosis With Polyangiitis Oct 28 (Reuters) - AstraZeneca PLC AZN.L : FASENRA APPROVED IN THE EU FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS Source text: ID:nWkrbSD9GZ Further company coverage: AZN.L
A

US natgas prices climb 2% to 2-week high on lower output, soaring global gas prices

UPDATE 1-US natgas prices climb 2% to 2-week high on lower output, soaring global gas prices Adds latest prices and rig count in Pennsylvania By Scott DiSavino Oct 25 (Reuters) - U.S. natural gas futures climbed about 2% to a two-week high on Friday on lower output so far this month and a jump in global gas prices that could boost demand for more U.S.
A
N

US natgas prices slide 2% on mild weather and low heating demand

US natgas prices slide 2% on mild weather and low heating demand By Scott DiSavino Oct 25 (Reuters) - U.S. natural gas futures slid about 2% on Friday on forecasts for mild weather through early November that should keep heating demand low and allow utilities to inject more gas into storage than is usual for this time of year. Front-month gas futures NGc1 for November delivery on the New York Mercantile Exchange fell 4.3 cents, or 1.7%, to $2.479 per million British thermal units (mmBtu) at 8:24
A
N

REUTERS SPORTS SCHEDULE AT 6:30 p.m. GMT/ 2:30 p.m. ET

REUTERS SPORTS SCHEDULE AT 6:30 p.m. GMT/ 2:30 p.m. ET Here are the top sports stories and upcoming coverage plans for Reuters text service as of 6:30 p.m. GMT/ 2:30 p.m. ET. For a full schedule of news and events, go to our editorial calendar on Reuters Connect . TOP STORIES BASEBALL-MLB PREVIEW-Baseball-Ohtani's extraordinary season lands him on doorstep of World Series title LOS ANGELES, Oct 24 (Reuters) - Shohei Ohtani's unprecedented first season with the Los Angeles Dodgers has brought the
A



Các điều kiện

Các tài sản phổ thông

Khước từ trách nhiệm: các tổ chức thuộc XM Group chỉ cung cấp dịch vụ khớp lệnh và truy cập Trang Giao dịch trực tuyến của chúng tôi, cho phép xem và/hoặc sử dụng nội dung có trên trang này hoặc thông qua trang này, mà hoàn toàn không có mục đích thay đổi hoặc mở rộng. Việc truy cập và sử dụng như trên luôn phụ thuộc vào: (i) Các Điều kiện và Điều khoản; (ii) Các Thông báo Rủi ro; và (iii) Khước từ trách nhiệm toàn bộ. Các nội dung như vậy sẽ chỉ được cung cấp dưới dạng thông tin chung. Đặc biệt, xin lưu ý rằng các thông tin trên Trang Giao dịch trực tuyến của chúng tôi không phải là sự xúi giục, mời chào để tham gia bất cứ giao dịch nào trên các thị trường tài chính. Giao dịch các thị trường tài chính có rủi ro cao đối với vốn đầu tư của bạn.

Tất cả các tài liệu trên Trang Giao dịch trực tuyến của chúng tôi chỉ nhằm các mục đích đào tạo/cung cấp thông tin và không bao gồm - và không được coi là bao gồm - các tư vấn tài chính, đầu tư, thuế, hoặc giao dịch, hoặc là một dữ liệu về giá giao dịch của chúng tôi, hoặc là một lời chào mời, hoặc là một sự xúi giục giao dịch các sản phẩm tài chính hoặc các chương trình khuyến mãi tài chính không tự nguyện.

Tất cả nội dung của bên thứ ba, cũng như nội dung của XM như các ý kiến, tin tức, nghiên cứu, phân tích, giá cả, các thông tin khác hoặc các đường dẫn đến trang web của các bên thứ ba có trên trang web này được cung cấp với dạng "nguyên trạng", là các bình luận chung về thị trường và không phải là các tư vấn đầu tư. Với việc các nội dung đều được xây dựng với mục đích nghiên cứu đầu tư, bạn cần lưu ý và hiểu rằng các nội dung này không nhằm mục đích và không được biên soạn để tuân thủ các yêu cầu pháp lý đối với việc quảng bá nghiên cứu đầu tư này và vì vậy, được coi như là một tài liệu tiếp thị. Hãy chắc chắn rằng bạn đã đọc và hiểu Thông báo về Nghiên cứu Đầu tư không độc lập và Cảnh báo Rủi ro tại đây liên quan đến các thông tin ở trên.

Cảnh báo rủi ro: Vốn của bạn bị rủi ro. Các sản phẩm có đòn bẩy có thể không phù hợp với tất cả mọi người. Hãy xem kỹ Thông báo rủi ro của chúng tôi.